Magnesium ion augmentation of inhibitory effects of adenosine on dopamine release in the rat striatum

Psychiatry and Clinical Neurosciences

Volumn 50, Issue 3, 1996, Pages 147-156

  Okada, Motohiro ^a   Mizuno, Kazuhisa ^a   Okuyama, Mizuho ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

adenosine receptor; calcium ion channel; dopamine release; magnesium ion; microdialysis; striatum

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; DOPAMINE; MAGNESIUM ION;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; MALE; MICRODIALYSIS; NONHUMAN; RAT;

EID: 0029996906     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.1996.tb01680.x     Document Type: Article

References (33)

1. Faggs GE, Foster AC, Ganong AH. Excitatory amino acid synaptic mechanisms and neurological function. TiPS 1986; 9: 357-366.
2. Williams M. Adenosine: the prototypic neuromodulator. Neuro-chem. Int. 1989; 19: 249-264.
3. Marangos PL. Potential therapeutic roles for adenosine in neuro-logic disease. In: Stone T. (ed.), Adenosine in the Nervous System. Academic Press, London, 1991; 217-227.
4. Williams M. Mammalian central adenosine receptors. In: Lajtha A (ed.), Handbook of Neurochemistry. 2nd edn. Vol. 6, Plenum Press, New York, 1984; 1-26.
5. Daly JW. Adenosine receptors. In: Cooper DMF, Seamon KB (eds), Advances in Cyclic Nucleotide and Protein Phosphorylation Research. Raven Press, New York, 1985; 29-46.
6. Phillis JA, Barraco RA. Adenosine, adenylate cyclase and transmitter release. In: Cooper DMF, Seamon KB (eds), Advances in Cyclic Nucleotide and Proteine Phosphorylation Research. Raven Press, New York, 1985; 243-257.
7. Riberio JA, Sebastiao AM. Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor. Prog. Neurobiol. 1986; 26: 179-209.
8. Fredholm BB, Dunwiddie TV. How does adenosine inhibit transmitter release? TiPS 1988; 9: 130-134.
9. Wojcik WJ, Neff NH. Differential location of adenosine A1 and A2 receptors in striatum. Neurosci. Lett. 1983; 41: 55-60.
10. Lee KS, Reddington M. Autoradiographic evidence for multiple CNS binding sites for adenosine derivates. Neuroscience 1986; 9: 535-549.
11. Wood PL, Kim HS, Boyar WC, Hutchison A. Inhibition of nigrostriatal release of dopamine in the rat by adenosine receptor agonist: Al receptor mediation. Neuropharmacology 1989; 28: 21-25.
12. Barraco RA, Stefano GB. Pharmacological evidence for the modulation of monoamine release by adenosine in the invertebrate nervous system. J. Neurochem. 1990; 54: 2002-2006.
13. Zetterstrom T, Fillens M. Adenosine agonist can both inhibit and enhance in vivo striatal dopamine release. Eur. J. Pharmacol. 1990; 180: 137-143.
14. 2+ dependence of membrane resistance increases evoked by NMDA in hippocampal membranes. Brain Res. 1984; 11: 392-396.
15. Nowak L, Bregestovki P, Ascher P, Herbert A, Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984; 307: 462-464.
16. Augustine GJ, Charlton MP, Smith SJ. Calcium action in synaptic transmitter release. Ann. Rev. Neurosci. 1987; 10: 633-693.
17. Westerink BHC, Hofsteede HM, Damsma G, de Vries JB. The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids, in conscious rats, evaluated by brain microdialysis. Naunyn- Schmiedeberg's Arch. Pharmacol. 1988; 337: 373-378.
18. Osborne PG, O'Connor WT, Ungerstedt U. Effects of varying the ionic concentration of a microdialysis perfusate on basal striatal dopamine levels in awake rats. J. Neurochem. 1991; 56: 452-456.
19. Gierschik P, McLeish K, Jakobs KH. Regulation of G-protein-mediated signal transfer by ions. J. Cardiovasc. Pharmacol. 1988; 12 (Suppl. 5): S20-24.
20. Birnbaumer L, Abramowitz J, Brown AM. Receptor-effector coupling by G proteins. Biochimica et Biophysica Acta 1990; 1013: 163-224.
21. 2, solubilization, and guanine nucleotides. J. Neurochem. 1990; 55: 1432-1438.
22. Johansson B, Parkinson FE, Fredholm BB. Effects of mono- and divalent ions on the binding of the adenosine analogus CGS 21680 to adenosine A2 receptors in rat striatum. Biochemical Pharmacol. 1992; 44: 2365-2370.
23. Bartrup JT, Stone TW. Interactions of adenosine and magnesium on rat hippocampal slices. Brain Res. 1988; 463: 374-379.
24. Stone TW, Connick JH, Bartrup JT. NMDA-receptor-independent effects of low magnesium: involvement of adenosine. Brain Res. 1990; 508: 333-336.
25. Okada M, Kaneko S, Hirano T et al. Effects of zonisamide on dopaminergic system. Epi. Res. 1995; 22: 193-205.
26. Moghaddam B, Bunney BS. Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J. Neurochem. 1989; 53: 652-654.
27. Williams M. Adenosine receptor agonists and antagonists. In: Stone T (ed.), Adenosine in the Nervous System. Academic Press, London, 1991; 137-171.
28. Spignoli G, Pedata F, Pepeu G. A1 and A2 adenosine receptors modulate acetylcholine release from brain slices. Eur. J. Pharmacol. 1984; 97: 341-342.
29. Reddington M, Lee KS. Adenosine receptor subtypes: Classification and distribution. In: Stone T (ed.), Adenosine in the Nervous System, Academic Press, London, 1991; 77-102.
30. 2+ current in hippocampal CA3 neurons. Neuron 1993; 10: 327-334.
31. Kaneko S, Okada M, Hirano T, Kondo T, Otani K, Fukushima Y. Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine does not antagonize adenosine effect in vitro: mechanisms of blockade of seizure spread. Jpn. J. Psychiatr. Neurol 1993; 47: 371-373.
32. Yeung S, Green R. Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5′-guanylylimido- phosphate or N-ethylmaleimide. J. Biol. Chem. 1983; 258: 2334-2339.
33. Parkinson FE, Fredholm BB. Magnesium-dependent enhancement of endogenous agonist binding to Al adenosine receptors: a complicating factor in quantitative autoradiography. J. Neurochem. 1992; 58: 941-950.